Local Tumor Control in Liver Malignancies Treated with Interstitial Brachytherapy (iBT)

Local Tumor Control in Liver Malignancies Treated with Interstitial Brachytherapy (iBT) - Local Tumor Control

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026787

Enrollment

300

Registered

2023-02-17

Start date

2021-11-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22

Interventions

Group 1: After approval by the ethics committee, the data will be analyzed. If data are already available, they will be analyzed retrospectively.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: HCC (Hepatocellular carcinoma) and oligometastatic CRC(Colorectal carcinoma) with interstitial brachytherapy(iBT)

Exclusion criteria

Exclusion criteria: no treatment interstitial brachytherapy(iBT) no HCC

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Progression-free survival	—

Countries

Germany

Contacts

Public ContactMax Seidensticker

LMU Klinikum

Max.Seidensticker@med.uni-muenchen.de+49 89/4400-76642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026